Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 1346390, 11 pages
Research Article

Epobis is a Nonerythropoietic and Neuroprotective Agonist of the Erythropoietin Receptor with Anti-Inflammatory and Memory Enhancing Effects

1Laboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
2Research Laboratory for Stereology and Neuroscience, Bispebjerg-Frederiksberg Hospital, Copenhagen University Hospital, Copenhagen, Denmark
3Juliane Marie Centret, Rigshospitalet (Copenhagen University Hospital), Copenhagen, Denmark

Received 2 May 2016; Revised 26 August 2016; Accepted 15 September 2016

Academic Editor: Mirella Giovarelli

Copyright © 2016 Oksana Dmytriyeva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • M. Moransard, M. Bednar, K. Frei, M. Gassmann, and O. O. Ogunshola, “Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms,” Journal of Neuroinflammation, vol. 14, no. 1, 2017. View at Publisher · View at Google Scholar
  • Ilkcan Ercan, Kemal Ugur Tufekci, Ezgi Karaca, Sermin Genc, and Kursad Genc, “Peptide Derivatives of Erythropoietin in the Treatment of Neuroinflammation and Neurodegeneration,” 2018. View at Publisher · View at Google Scholar
  • Oksana Dmytriyeva, Amor Belmeguenai, Laurent Bezin, Katia Soud, David Paul Drucker Woldbye, Casper René Gøtzsche, and Stanislava Pankratova, “Short erythropoietin-derived peptide enhances memory, improves long-term potentiation, and counteracts amyloid beta-induced pathology,” Neurobiology of Aging, 2019. View at Publisher · View at Google Scholar